QCM
TXG icon

Quantinno Capital Management’s 10x Genomics TXG Stock Holding History

Quantinno Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210M Buy
5,469,698
+57,937
+1% +$1.52M 0.25% 42
2026
Q1 		$115M Buy
5,411,761
+744,558
+16% +$14.9M 0.19% 64
2025
Q4 		$76.1M Buy
4,667,203
+1,174,744
+34% +$17.7M 0.15% 98
2025
Q3 		$40.8M Buy
3,492,459
+1,258,933
+56% +$16.4M 0.11% 190
2025
Q2 		$25.9M Buy
2,233,526
+1,506,530
+207% +$13.7M 0.11% 190
2025
Q1 		$6.35M Buy
726,996
+577,163
+385% +$7.28M 0.04% 550
2024
Q4 		$2.15M Sell
149,833
-85,193
-36% -$1.34M 0.02% 820
2024
Q3 		$5.31M Buy
235,026
+186,111
+380% +$3.85M 0.07% 335
2024
Q2 		$951K Buy
48,915
+25,852
+112% +$677K 0.02% 823
2024
Q1 		$866K Sell
23,063
-20,252
-47% -$890K 0.02% 778
2023
Q4 		$2.42M Buy
43,315
+33,902
+360% +$1.48M 0.08% 301
2023
Q3 		$388K Sell
9,413
-20,009
-68% -$1.04M 0.02% 802
2023
Q2 		$1.64M Buy
+29,422
New +$1.59M 0.09% 273

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantinno Capital Management's TXG Position: Q2 2026 in Review

Quantinno Capital Management increased its 10x Genomics (TXG) stake by 1.1% in Q2 2026, buying an estimated $1.52M and bringing the position to 5,469,698 shares worth $210M. The position accounts for 0.25% of the portfolio, ranked #42.

Quantinno Capital Management first reported a position in TXG in Q2 2023 and has held it in 13 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Quantinno Capital Management held 5,469,698 shares of 10x Genomics worth $210M as of Q2 2026.
  • Quantinno Capital Management bought 57,937 10x Genomics shares in Q2 2026, an estimated $1.52M.
  • 10x Genomics made up 0.25% of Quantinno Capital Management's portfolio in Q2 2026, its #42 holding.
  • Quantinno Capital Management first reported a position in 10x Genomics in Q2 2023 and has held it in 13 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.